References
- Kinlay S. Changes in stroke epidemiology, prevention, and treatment. Circulation 2011;124:e494–e496
- Bath PM, Lees KR, Schellinger PD, Altman H, Bland M, Hogg C, Howard G, Saver JL; European Stroke Organisation Outcomes Working Group. Statistical analysis of the primary outcome in acute stroke trials. Stroke 2012;43:1171–1178
- Hermann DM, Chopp M. Promoting brain remodelling and plasticity for stroke recovery: Therapeutic promise and potential pitfalls of clinical translation. Lancet Neurol 2012;11:369–380
- Chen Y, Aulia S, Tang BL. Myelin-associated glycoprotein-mediated signaling in central nervous system pathophysiology. Molecular Neurobiology 2006;34:81–91
- Cao Z, Gao Y, Deng K, Williams G, Doherty P, Walsh FS. Receptors for myelin inhibitors: Structures and therapeutic opportunities. Molecular and Cellular Neuroscience 2010;43:1–14
- McDonald CL, Bandtlow C, Reindl M. Targeting the Nogo receptor complex in diseases of the central nervous system. Current Medicinal Chemostry 2011;18:234–244
- Gou X, Wang Q, Yang Q, Xu L, Xiong L. TAT-NEP1-40 as a novel therapeutic candidate for axonal regeneration and functional recovery after stroke. Journal of Drug Targeting 2011;19:86–95
- Wang Q, Gou X, Xiong L, Jin W, Chen S, Hou L, Xu L. Trans-activator of transcription-mediated delivery of NEP1-40 protein into brain has a neuroprotective effect against focal cerebral ischemic injury via inhibition of neuronal apoptosis. Anesthesiology 2008;108:1071–1080
- Teng FY, Tang BL. Why do Nogo/Nogo-66 receptor gene knockouts result in inferior regeneration compared to treatment with neutralizing agents? Journal of Neurochemistry 2005;94:865–874
- Atwal JK, Pinkston-Gosse J, Syken J, Stawicki S, Wu Y, Shatz C, Tessier-Lavigne M. PirB is a functional receptor for myelin inhibitors of axonal regeneration. Science 2008;322:967–970
- Filbin MT. PirB, a second receptor for the myelin inhibitors of axonal regeneration Nogo66, MAG, and OMgp: Implications for regeneration in vivo. Neuron 2008;60:740–742
- Adelson JD, Barreto GE, Xu L, Kim T, Brott BK, Ouyang YB, Naserke T, Djurisic M, Xiong X, Shatz CJ, Giffard RG. Neuroprotection from stroke in the absence of MHCI or PirB. Neuron 2012;73:1100–1107
- Dennis G Jr, Stephan RP, Kubagawa H, Cooper MD. Characterization of paired Ig-like receptors in rats. Journal of Immunology 1999;163:6371–6377
- Wang Q, Peng Y, Chen S, Gou X, Hu B, Du J, Lu Y, Xiong L. Pretreatment with electroacupuncture induces rapid tolerance to focal cerebral ischemia through regulation of endocannabinoid system. Stroke 2009;40:2157–2164
- Ashwal S, Tone B, Tian HR, Cole DJ, Pearce WJ. Core and penumbral nitric oxide synthase activity during cerebral ischemia and reperfusion. Stroke 1998;29:1037–1046; discussion 1047
- Donnan GA, Fisher M, Macleod M, Davis SM. Stroke. Lancet 2008;371:1612–1623
- Stinear C. Prediction of recovery of motor function after stroke. Lancet Neurology 2010;9:1228–1232
- Boncoraglio GB, Bersano A, Candelise L, Reynolds BA, Parati EA. Stem cell transplantation for ischemic stroke. Cochrane Database System Review 2010. Art. No.: CD007231. doi: 10.1002/14651858.CD007231
- Ferrarello F, Baccini M, Rinaldi LA, Cavallini MC, Mossello E, Masotti G, Marchionni N, Di Bari M. Efficacy of physiotherapy interventions late after stroke: A meta-analysis. Journal of Neurology, Neurosurgery & Psychiatry 2011;82:136–143
- Langhorne P, Bernhardt J, Kwakkel G. Stroke rehabilitation. Lancet 2011;377:1693–1702
- Kastin AJ, Pan W. Targeting neurite growth inhibitors to induce CNS regeneration. Current Pharmaceutical Design 2005;11:1247–1253
- Zheng B, Atwal J, Ho C, Case L, He XL, Garcia KC, Steward O, Tessier-Lavigne M. Genetic deletion of the Nogo receptor does not reduce neurite inhibition in vitro or promote corticospinal tract regeneration in vivo. Proceedings of the National Academy of Sciences USA 2005;102:1205–1210
- Chen CC, Hurez V, Brockenbrough JS, Kubagawa H, Cooper MD. Paternal monoallelic expression of the paired immunoglobulin-like receptors PIR-A and PIR-B. Proceedings of the National Academy of Sciences USA 1999;96:6868–6872
- Pereira S, Zhang H, Takai T, Lowell CA. The inhibitory receptor PIR-B negatively regulates neutrophil and macrophage integrin signaling. Journal of Immunology 2004;173:5757–5765
- Syken J, Grandpre T, Kanold PO, Shatz CJ. PirB restricts ocular-dominance plasticity in visual cortex. Science 2006;313:1795–1800